Last edition
News about "Competitive Generic Therapy "
Glenmark Specialty SA Receives US FDA Approval for Fluticasone Propionate Inhalation Aerosol USP
Glenmark Pharmaceuticals’s subsidiary Glenmark Specialty SA has received approval from the US Food and Drug Administration (FDA) for Fluticasone Propionate Inhalation Aerosol USP, 44 mcg per actuation, along with 180-day Competitive Generic Therapy exclusivity. The product has been deemed bioequivalent and therapeutically equivalent to Flovent HFA.
Competitive Generic Therapy | 05/03/2026 | By Akanki | 101
Lupin Gets Approval from US FDA for Prednisolone Acetate Ophthalmic Suspension
Lupin has secured approval from US FDA for its Abbreviated New Drug Application (ANDA) for Prednisolone Acetate Ophthalmic Suspension USP, 1 percent to market a generic equivalent of Pred Forte Ophthalmic Suspension, 1 percent, of AbbVie Inc.
Competitive Generic Therapy | 07/08/2024 | By Aishwarya | 625
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy